Naringenin and 17β-estradiol coadministration prevents hormone-induced human cancer cell growth

IUBMB Life

Volumn 62, Issue 1, 2010, Pages 51-60

  Bulzomi, Pamela ^a   Bolli, Alessandro ^a,b   Galluzzo, Paola ^a   Leone, Stefano ^a   Acconcia, Filippo ^a   Marino, Maria ^a,b  

^a ROMA TRE UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

17 estradiol; Cell proliferation; Estrogen receptor ; Naringenin

Indexed keywords

CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NARINGENIN; PROTEIN KINASE B; ANTIESTROGEN; ANTINEOPLASTIC AGENT; FLAVANONE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; CELL CYCLE; CELL STRAIN HEPG2; CELL SURVIVAL; DRUG EFFECT; GENETICS; HELA CELL; METABOLISM; NEOPLASM; PROMOTER REGION; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESTRADIOL; ESTROGEN ANTAGONISTS; FLAVANONES; HELA CELLS; HEP G2 CELLS; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION;

EID: 77950571618     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.279     Document Type: Article

References (44)

1. Galluzzo, P. and Marino, M. (2006) Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities. Genes Nutr. 1, 161-176.
2. Adlercreutz, H., Heinonen, S. M., and Penalvo-Garcia, J. (2004) Phytoestrogens, cancer and coronary heart disease. Biofactors 22, 229-236.
3. Birt, D. F., Hendrich, S., and Wang, W. (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Therap. 90, 157-177.
4. Moutsatsou, P. (2007) The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones 6, 173-193.
5. Marino, M. and Bulzomi, P. (2009) Mechanisms at the root of flavonoid action in cancer: a step toward solving the Rubik's cube. In Flavonoids: Biosynthesis, Biological Effects and Dietary Sources. (Keller, R. B., ed.). Nova Science Publisher, New York (In Press).
6. Virgili, F. and Marino, M. (2008) Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic. Biol. Med. 45, 1205-1216.
7. Manach, C., Manach, A., Morand, S. C., Remesy, C., and Jimenez, L. (2004) Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727-747.
8. Totta, P., Acconcia, F., Leone, S., Cardillo, I., and Marino, M. (2004) Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor α and β signalling. IUBMB Life 56, 491-499. (Pubitemid 39582784)
9. Saarinen, N. M., Mäkelä, S., Penttinen, P., Wärri, A., Lorenzetti, S., Virgili, F., Mortensen, A., Sørensen, I. K., Bingham, C., Valsta, L. M., Vollmer, G., and Zierau, O. (2006) Tools to evaluate estrogenic potency of dietary phytoestrogens: a consensus paper from the EU Thematic Network "Phytohealth" (QLKI-2002-2453). Genes Nutr. 1, 143-158.
10. Virgili, F., Acconcia, F., Ambra, R., Rinna, A., Totta, P., and Marino, M. (2004) Nutritional flavonoids modulate estrogen receptor α signaling. IUBMB Life 56, 145-151. (Pubitemid 38678570)
11. Galluzzo, P., Ascenzi, P., Bulzomi, P., and Marino, M. (2008) The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor α-palmitoylation. Endocrinology 149, 2567-2575. (Pubitemid 351577394)
12. Acconcia, F., Totta, P., Ogawa, S., Cardillo, I., Inoue, S., Leone, S., Trentalance, A., Muramatsu, M., and Marino, M. (2005) Survival versus apoptotic 17β-estradiol effect: role of ERα and ERβ activated nongenomic signaling. J. Cell. Physiol. 203, 193-201.
13. Ascenzi, P., Bocedi, A., and Marino, M. (2006) Structure-function relationship of estrogen receptor α and β: impact on human health. Mol. Aspects Med. 27, 299-402.
14. Bolli, A., Galluzzo, P., Ascenzi, P., Del Pozzo, G., Manco, I., Vietri, M. T., Mita, L., Altucci, L., Mita, D. G., and Marino, M. (2008) Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor α-dependent rapid signals. IUBMB Life 60, 843-852.
15. Antonini, E., and Brunori, M. (1971) Hemoglobin and Myoglobin in their Reactions with Ligands. North Holland Publishing Co., Amsterdam and London.
16. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
17. Herbert, B., Truss, M., Beato, M., and Müller, R. (1994) Inducibile regulatory elements in the human cyclin D1 promoter. Oncogene 9, 1295-1304. (Pubitemid 24095043)
18. Castoria, G., Migliaccio, A., Bilancio, A., Di Domenico, M., de Falco, A., Lombardi, M., Fiorentino, R., Varricchio, L., Barone, M. V., and Auricchio, F. (2001) PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20, 6050-6059. (Pubitemid 33049280)
19. Deroo, B. J., and Korach, K. S. (2006) Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570.
20. Matthews, J., and Gustafsson, J.-Å. (2003) Estrogen signalling: a subtle balance between ERα and ERβ. Mol. Interv. 3, 281-292.
21. Koehler, K. F., Helguero, L. A., Haldosen, L. A., Warner, M., and Gustafsson, J.-Å. (2005) Reflections on the discovery and significance of estrogen receptor b. Endocr. Rev. 26, 465-478.
22. Korach, K. S., Emmen, J. M., Walker, V. R., Hewitt, S. C., Yates, M., Hall, J. M., Swope, D. L., Harrell, J. C., and Couse, J. F. (2003) Update on animal models developed for analyses of estrogen receptor biological activity. J. Steroid. Biochem. Mol. Biol. 86, 387-391.
23. Strom, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., and Gustafsson, J.-Å. (2004) Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl. Acad. Sci. USA 101, 1566-1571.
24. Dixon, R. A. (2004) Phytoestrogens. Ann. Rev. Plant Biol. 55, 225-261.
25. Konstantakopoulos, N., Montgomery, K. G., Chamberlain, N., Quinn, M. A., Baker, M. S., Rice, G. E., Georgiou, H. M., and Campbell, I. G. (2006). Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol. Carcinog. 45, 752-763.
26. Martínez, C., Vicente, V., Yáñez, J., Alcaraz, M., Castells, M. T., Canteras, M., Benavente-García, O., and Castillo, J. (2005) The effect of the flavonoid diosmin, grape seed extract and red wine on the pulmonary metastatic B16F10 melanoma. Histol. Histopathol. 20, 1121-1129.
27. McCarty, M. F., Barroso-Aranda, J., and Contreras, F. (2009) Genistein and phycocyanobilin may prevent hepatic fibrosis by suppressing proliferation and activation of hepatic stellate cells. Med. Hypotheses 72, 330-332.
28. McCarty, M. F. (2006) Isoflavones made simple - genistein's agonist activity for the β-type estrogen receptor mediates their health benefits. Med. Hypotheses 66, 1093-1114
29. Messina, M. and Wu, A. H. (2009) Perspectives on the soy-breast cancer relation. Am. J. Clin. Nutr. 89, 1673S-1679S.
30. Rice, S. and Whitehead, S. A. (2006). Phytoestrogens and breast cancer-promoters or protectors? Endocr. Relat. Cancer 13, 995-1015.
31. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J.-Å. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870. (Pubitemid 27089735)
32. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J.-Å. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263. (Pubitemid 28513713)
33. Ruh, M. F., Zacharewski, T., Connor, K., Howell, J., Chen, I., and Safe, S. H. (1995) Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem. Pharmacol. 26, 1485-1493.
34. Safe, S. H. and Kim, K. (2008) Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 41, 263-275.
35. Harris, D. M., Besselink, E., Henning, S. M., Go, V. L. W., and Heber, D. (2005) Phytoestrogens induce differential estrogen receptor α- or β-mediated responses in transfected breast cancer cells. Exp. Biol. Med. 230, 558-568.
36. Farach-Carson, M. C. and Davis, P. J. (2003) Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J. Pharmacol. Exper. Therap. 30, 839-845.
37. Kousteni, S., Chen, J. R., Bellido, T., Han, L., Ali, A. A., O'Brien, C. A., Plotkin, L., Fu, Q., Mancino, A. T., Wen, Y., Vertino, A. M., Powers, C. C., Stewart, S. A., Ebert, R., Parfitt, A. M., Weinstein, R. S., Jilka, R. L., and Manolagas, S. C. (2002) Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298, 843-846. (Pubitemid 35231540)
38. Chambliss, K. L., Simon, L., Yuhanna, I. S., Mineo, C., and Shaul, P. W. (2005) Dissecting the basis of nongenomic activation of eNOS by estradiol: role of ERα domains with known nuclear functions. Mol. Endocrinol. 19, 277-289.
39. Sarkar, F. H., and Li, Y. (2002) Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev. 21, 265-280. (Pubitemid 36071914)
40. Magee, P. J. and Rowland, I. R. (2004) Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br. J. Nutr. 91, 513-531.
41. Erlund, I., Meririnne, E., Alfthan, G., and Aro, A. (2001) Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J. Nutr. 131, 235-241. (Pubitemid 32115362)
42. Harmon, A. W. and Patel, Y. M. (2004) Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res. Treat. 85, 103-110.
43. Katzenellenbogen, J. A. and Muthyala, R. S. (2003) Interactions of exogenous endocrine active substances with nuclear receptors. Pure Appl. Chem. 75, 1797-1817.
44. Whitten, P. L., Lewis, C., Russell, E., and Naftolin, F. (1995) Potential adverse effects of phytoestrogens. J. Nutr. 125, 771S-776S.